NCT04096742

Altreno for Chest Rejuvenation

A Prospective, Randomized, Double-blind, Vehicle-controlled Study Evaluating the Efficacy, Safety and Patient Satisfaction of Tretinoin 0.05% Lotion (Altreno) for Chest Rejuvenation.

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This is a single-center, prospective, double-blind, randomized, vehicle-controlled study to evaluate the efficacy, safety and patient satisfaction of tretinoin 0.05% lotion (Altreno) for chest rejuvenation.

Conditions

• Photodamaged Skin
• Photoaging

Interventions

Type	Name	Description
DRUG	tretinoin 0.05% lotion (Altreno)	Altreno topical lotion
OTHER	Vehicle	Lotion not containing active ingredient (tretinoin)

Timeline

• Start date: 2019-08-06
• Primary completion: 2021-07-30
• Completion: 2021-12-31
• First posted: 2019-09-20
• Last updated: 2021-04-02

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study